These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 11723064)

  • 1. PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance.
    Guerre-Millo M; Rouault C; Poulain P; André J; Poitout V; Peters JM; Gonzalez FJ; Fruchart JC; Reach G; Staels B
    Diabetes; 2001 Dec; 50(12):2809-14. PubMed ID: 11723064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-alpha deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet: hyperinsulinemic-euglycemic clamp studies.
    Haluzik M; Gavrilova O; LeRoith D
    Endocrinology; 2004 Apr; 145(4):1662-7. PubMed ID: 14670996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased glucose tolerance in N-type Ca2+ channel alpha(1B)-subunit gene-deficient mice.
    Takahashi E; Ito M; Miyamoto N; Nagasu T; Ino M; Tanaka I
    Int J Mol Med; 2005 Jun; 15(6):937-44. PubMed ID: 15870896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective modification of pyruvate dehydrogenase kinase isoform expression in rat pancreatic islets elicited by starvation and activation of peroxisome proliferator-activated receptor-alpha: implications for glucose-stimulated insulin secretion.
    Sugden MC; Bulmer K; Augustine D; Holness MJ
    Diabetes; 2001 Dec; 50(12):2729-36. PubMed ID: 11723055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-alpha deficiency protects aged mice from insulin resistance induced by high-fat diet.
    Cha DR; Han JY; Su DM; Zhang Y; Fan X; Breyer MD; Guan Y
    Am J Nephrol; 2007; 27(5):479-82. PubMed ID: 17652964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased insulin secretion and normalization of glucose tolerance by cholinergic agonism in high fat-fed mice.
    Ahrén B; Sauerberg P; Thomsen C
    Am J Physiol; 1999 Jul; 277(1):E93-102. PubMed ID: 10409132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production.
    Xu J; Xiao G; Trujillo C; Chang V; Blanco L; Joseph SB; Bassilian S; Saad MF; Tontonoz P; Lee WN; Kurland IJ
    J Biol Chem; 2002 Dec; 277(52):50237-44. PubMed ID: 12176975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute (24 h) activation of peroxisome proliferator-activated receptor-alpha (PPARalpha) reverses high-fat feeding-induced insulin hypersecretion in vivo and in perifused pancreatic islets.
    Holness MJ; Smith ND; Greenwood GK; Sugden MC
    J Endocrinol; 2003 May; 177(2):197-205. PubMed ID: 12740007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation.
    Ye JM; Doyle PJ; Iglesias MA; Watson DG; Cooney GJ; Kraegen EW
    Diabetes; 2001 Feb; 50(2):411-7. PubMed ID: 11272155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice.
    Ahrén B; Simonsson E; Scheurink AJ; Mulder H; Myrsén U; Sundler F
    Metabolism; 1997 Jan; 46(1):97-106. PubMed ID: 9005977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of peroxisome proliferator-activated receptor-alpha in the modulation of glucose-stimulated insulin secretion.
    Sugden MC; Holness MJ
    Diabetes; 2004 Feb; 53 Suppl 1():S71-81. PubMed ID: 14749269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets.
    Lalloyer F; Vandewalle B; Percevault F; Torpier G; Kerr-Conte J; Oosterveer M; Paumelle R; Fruchart JC; Kuipers F; Pattou F; Fiévet C; Staels B
    Diabetes; 2006 Jun; 55(6):1605-13. PubMed ID: 16731822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet.
    Matsui J; Terauchi Y; Kubota N; Takamoto I; Eto K; Yamashita T; Komeda K; Yamauchi T; Kamon J; Kita S; Noda M; Kadowaki T
    Diabetes; 2004 Nov; 53(11):2844-54. PubMed ID: 15504964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency.
    Miles PD; Barak Y; He W; Evans RM; Olefsky JM
    J Clin Invest; 2000 Feb; 105(3):287-92. PubMed ID: 10675354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet.
    Nunemaker CS; Chen M; Pei H; Kimble SD; Keller SR; Carter JD; Yang Z; Smith KM; Wu R; Bevard MH; Garmey JC; Nadler JL
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1065-75. PubMed ID: 18780776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinin B1 receptor deficiency protects mice fed by cafeteria diet from abnormal glucose homeostasis.
    Correia PE; Gomes CB; Bandeira VA; Marten T; Natividade GR; Merello P; Tozawa E; Cerski CTS; Budu A; Araújo R; Arbo BD; Ribeiro MFM; Barros CC; Gerchman F
    PLoS One; 2022; 17(5):e0267845. PubMed ID: 35617279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered beta-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6J mice.
    Reimer MK; Ahrén B
    Diabetes; 2002 Feb; 51 Suppl 1():S138-43. PubMed ID: 11815473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic islet response to hyperglycemia is dependent on peroxisome proliferator-activated receptor alpha (PPARalpha).
    Bihan H; Rouault C; Reach G; Poitout V; Staels B; Guerre-Millo M
    FEBS Lett; 2005 Apr; 579(11):2284-8. PubMed ID: 15848159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity.
    Watson E; Hahm S; Mizuno TM; Windsor J; Montgomery C; Scherer PE; Mobbs CV; Salton SR
    Endocrinology; 2005 Dec; 146(12):5151-63. PubMed ID: 16141392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of G protein-coupled receptor 39 impairs insulin secretion in vivo.
    Tremblay F; Richard AM; Will S; Syed J; Stedman N; Perreault M; Gimeno RE
    Endocrinology; 2009 Jun; 150(6):2586-95. PubMed ID: 19213841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.